Inovio Pharma (INO) Reports Q1 Loss of $0.30/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 --0%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
COE, BEKE, BJ, More
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
COE, BEKE, BJ, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.30), versus ($0.36) reported last year. Revenue for the quarter came in at $2.83 million, versus $1.53 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Jefferies Downgrades Alfen (ALFEN:NA) (ALFNF) to Hold
- UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
